Researcher Profile

Researcher Profile

Matthew G. Kaag, MD

Matthew G. Kaag, MD

Associate Professor, Department of Urology
Associate Professor, Department of Surgery
Scientific Program:Cancer Control
Disease Teams:
Genitourinary Cancer

Research Interests

  • Neoplasms
  • Urinary Bladder Neoplasms
  • Carcinoma
  • Kidney
  • Nephrectomy
  • Therapeutics
  • Renal Cell Carcinoma
  • Drug Therapy
  • Nephroureterectomy
  • Recurrence
  • Survival
  • Cystectomy

Clinical Trials

Phase III Randomized Trial Of Concurrent Chemoradiotherapy With or Without Atezoluzumab in Localized Muscle Invasive Bladder Cancer
Phase 2 Study of Bladder-SparIng ChemoradiatioN with CIPosItive bladdeR cancEr (INSPIRE)EA8185
A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer
Randomized Phase III Trial Incorporating Abiraterone Acetate with Prednisone and Apalutamide and Advanced Imaging Into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)
BTCRC-GU19-404 -A Single Arm, Phase I/II Trial of Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men with Localized, High Risk Prostate Cancer
Enhancing Patient Resilience During Multimodal Therapy for Bladder Cancer
Creation of a Clinical and Pathologic Tissue Microarray Registry for Radical Cystectomy Specimens
Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer

Recent Publications


Loloi, J, Eccles, JM, Owens, G, Lehman, E, Kaag, MG, Raman, JD & Merrill, SB 2022, 'Diagnostic Imaging in Low-Risk Prostate Cancer: More Harm Than Good?', Urology Practice, vol. 9, no. 2, pp. 135-139.
Strausser, SA, Owens, RG, Vu, T, Kwok, E, Schaefer, EW, Boltz, S, Aminsharifi, A, Kaag, M, Raman, JD & Merrill, SB 2022, 'Patient Perceptions Regarding Routine Oncologic Follow-Up for Urologic Malignancies', Clinical Genitourinary Cancer, vol. 20, no. 3, pp. 298-298.e11.


Grant Owens, R, Loloi, J, Lehman, EB, Kaag, MG, Raman, JD & Merrill, SB 2021, 'Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?', Urologic Oncology: Seminars and Original Investigations, vol. 39, no. 7, pp. 433.e9-433.e15.
Ramedani, S, Clark, JY, Knoedler, JJ, MacDonald, S, Kaag, MG, Merrill, SB & Raman, JD 2021, 'Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship', Prostate International, vol. 9, no. 4, pp. 185-189.


Fuletra, JG, Watts, A, Kaag, MG, Lehman, E, Raman, JD & Merrill, SB 2020, 'Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy?', World Journal of Urology.
Lee, CT, Mohamed, NE, Pisipati, S, Shah, QN, Agarwal, PK, Downs, TM, Droller, M, Gilbert, SM, Goltz, HH, Hall, SJ, Hendawi, M, Hoffman-Censits, J, O'Donnell, M, Kaag, M, Karsh, LI, Kassouf, W, Quale, DZ, Sagalowsky, A, Steinberg, GD & Latini, DM 2020, 'Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: A multi-methods approach', BMC health services research, vol. 20, no. 1, 686.
Li, H, Zhang, Q, Shuman, L, Kaag, M, Raman, JD, Merrill, S, DeGraff, DJ, Warrick, JI & Chen, G 2020, 'Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes', Scientific reports, vol. 10, no. 1, 1439.
Durant, AM, Lehman, E, Robyak, H, Merrill, SB, Kaag, MG & Raman, JD 2020, 'Hemostatic agent use during partial nephrectomy: trends, outcomes, and associated costs', International Urology and Nephrology, vol. 52, no. 11, pp. 2073-2078.
Loloi, J, Allen, JL, Schilling, A, Hollenbeak, C, Merrill, SB, Kaag, MG & Raman, JD 2020, 'In the World of Bladder Tumors: Size Does Matter', Bladder Cancer, vol. 6, no. 2, pp. 195-200.
Kaag, MG 2020, 'Tract urothelial cancers', Translational Andrology and Urology, vol. 9, no. 4, pp. 1881-1890.


Buckwalter, JM, Chan, W, Shuman, L, Wildermuth, T, Ellis-Mohl, J, Walter, V, Warrick, JI, Wu, XR, Kaag, M, Raman, JD & Degraff, DJ 2019, 'Characterization of histone deacetylase expression within in vitro and in vivo bladder cancer model systems', International journal of molecular sciences, vol. 20, no. 10, 2599.
Kaag, MG 2019, 'Editorial Comment', Journal of Urology, vol. 202, no. 1, pp. 82.
Zaleski, M, Gogoj, A, Walter, V, Raman, JD, Kaag, M, Merrill, SB, Drabick, J, Joshi, M, Holder, S, DeGraff, DJ & Warrick, JI 2019, 'Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system', Human Pathology, vol. 84, pp. 275-282.
Yamashita, H, Kawasawa, YI, Shuman, L, Zheng, Z, Tran, T, Walter, V, Warrick, JI, Chen, G, Al-Ahmadie, H, Kaag, M, Wong, PK, Raman, JD & DeGraff, DJ 2019, 'Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancer', Oncogenesis, vol. 8, no. 12, 69.
Bodo, S, Campagne, C, Thin, TH, Higginson, DS, Vargas, HA, Hua, G, Fuller, JD, Ackerstaff, E, Russell, J, Zhang, Z, Klingler, S, Cho, HJ, Kaag, MG, Mazaheri, Y, Rimner, A, Manova-Todorova, K, Epel, B, Zatcky, J, Cleary, CR, Rao, SS, Yamada, Y, Zelefsky, MJ, Halpern, HJ, Koutcher, JA, Cordon-Cardo, C, Greco, C, Haimovitz-Friedman, A, Sala, E, Powell, SN, Kolesnick, R & Fuks, Z 2019, 'Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury', Journal of Clinical Investigation, vol. 129, no. 2, pp. 786-801.


Merrill, SB, Sohl, BS, Hamirani, A, Lehman, EB, Lehman, KK, Kaag, MG & Raman, JD 2019, 'Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival', Clinical Genitourinary Cancer, vol. 17, no. 2, pp. 132-138.
Blair, BM, Robyak, H, Clark, JY, Kaag, MG, Lehman, EB & Raman, JD 2018, 'Impact of United States Preventive Services Task Force recommendations on prostate biopsy characteristics and disease presentation at a tertiary-care medical center', Prostate International, vol. 6, no. 3, pp. 110-114.
Warrick, JI, Sjödahl, G, Kaag, M, Raman, JD, Merrill, S, Shuman, L, Chen, G, Walter, V & DeGraff, DJ 2019, 'Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants [Figure presented]', European Urology, vol. 75, no. 1, pp. 18-22.
Blair, BM, Lehman, EB, Jafri, SM, Kaag, MG & Raman, J 2018, 'Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma', International Urology and Nephrology, vol. 50, no. 7, pp. 1249-1256.
Kaag, MG & Raman, JD 2018, 'Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer', Translational Andrology and Urology, vol. 7, pp. S732-S734.
Park, R, Gyorfi, J, Dewan, K, Kirimanjeswara, G, Clark, JY, Kaag, MG, Lehman, K & Raman, JD 2018, 'Topical rectal antiseptic at time of prostate biopsy: how a resident patient safety project has evolved into institutional practice', International Urology and Nephrology, vol. 50, no. 9, pp. 1563-1568.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)